Global Oncology Information Systems Industry: Post-COVID Growth Opportunity Analysis, Key Players | Accuray Incorporated, Bogardus Medical Systems, and Cerner Corporation.

The global Oncology Information Systems market size was valued at $6.94 Billion in 2020 and is expected to reach $12.01 Billion by 2028 growing at the CAGR of 7.02% from 2021 to 2028.

The rapid growth of healthcare technology, increasing cases of cancer, high investments in the oncology segment for treatment and care, and widespread adoption of OIS solutions are anticipated to drive the Oncology Information System (OIS) market. A large number of novel technologies are currently under development, which has the potential to change the treatment regime drastically.

The Oncology Information System (OIS) is used by organizations and health-center providers to process and store information for cancer patients, which has provided many solutions that will help facilitate effective communication between healthcare professionals. In light of these benefits, governments and well-established companies are investing more in research into oncology treatments, which is expected to drive this market over the forecast period.

Request Free Sample Report or PDF Copy: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=005502

Key Players

Some of the major Oncology Information Systems players holding high market share include Accuray Incorporated, Bogardus Medical Systems, and Cerner Corporation. These players use new product development and expansion as a key strategy to gain significant market share to compete with market leaders.

The key players profiled in the report are:
● Accuray Incorporated
● Bogardus Medical Systems
● Cerner Corporation
● CUREMD CORPORATION
● Elekta AB
● Flatiron Health
● Koninklijke Philips N.V.
● McKesson Corporation
● RaySearch Laboratories AB
● Varian Medical Systems

The recently published research report on Global Oncology Information Systems Market by Evolve Business Intelligence examines the industry in the context of major market aspects including market size & forecast, market shares in terms of revenues and volume, key players, and SWOT analysis. The market is analyzed based on 4 separate indications in the market dynamic chapter: Drivers, Restraints, Key Trends, and Challenges. The total sum of these sections will help you understand what strategies will be best to adopt in order to prosper through this industry over a few short years. The quantitative analysis includes our actual findings out of this research study where we provided additional insight into what our readers can do to embrace new opportunities or plan against threats that might hinder the market.

The COVID-19 pandemic has led to disruption in the supply chain leading to lower demand or supply shortages in the Oncology Information Systems market. The travel restrictions and social-distancing measures have resulted in a sharp drop in consumer and business spending and this pattern is expected to continue for some time. The end-user trend and preferences have changed due to the pandemic and have resulted in manufacturers, developers, and service providers adopting various strategies to stabilize the company.

The New Normal

As businesses recover from the COVID-19 pandemic, they have a new set of priorities to cope with. Throughout this crisis, they were forced to deal with shifting situations and often fell short of their ultimate goals. Now that a cure has been found and the pandemic is dying down, they will need to recuperate from this epidemic by setting forth new objectives to succeed in the future.

In terms of COVID 19 impact, the Oncology Information Systems market report also includes the following data points:
● COVID19 Impact on Oncology Information Systems market size
● End-User/Industry/Application Trend, and Preferences
● Government Policies/Regulatory Framework
● Key Players Strategy to Tackle Negative Impact/Post-COVID Strategies
● Opportunity in Oncology Information Systems market

Segmental Analysis

Market Segment by Products with a focus on market share, consumption trend, and growth rate of Oncology Information Systems Market:
o Software
o Services

Market Segment by Application with the focus on market share, consumption trend, and growth rate of Oncology Information Systems Market:
o Radiation Oncology
o Medical Oncology
o Surgical Oncology

For more information: https://evolvebi.com/product/oncology-information-systems-market-analysis-and-global-forecast-2020-2028-with-covid-impact-analysis/

Key Region/ Countries Covered
● North America (US, Canada, Mexico)
● Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
● Asia-Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
● Rest of the World (the Middle East & Africa and South America)

North America dominated the oncology information systems market and accounted for the largest revenue share. Key factors responsible for this growth include sophisticated healthcare infrastructure and increasing awareness about patient information management in the region. Moreover, the growing adoption of oncology information systems to track and record treatment results of cancer patients and the rising importance of EMR to make better treatment decisions are some of the key factors boosting demand for oncology information systems. Furthermore, the increasing need to manage complex treatment schedules, dose management, and treatment planning are expected to drive growth in this region.

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Contact: +1 773 644 5507 / +91 635 396 3987
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging the pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool – EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortune’s global 2000 companies.

This release was published on openPR.